NEUT-RI, a surrogate marker of NETosis is lower in patients with strong IgM antiphospholipid antibodies
Journal of Thrombosis and Thrombolysis · 2024
DOI: 10.1007/s11239-024-03001-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Thrombolysis, 2024. Verfasst von Sylvie Bouvier und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nîmes University Hospital, Place du Professeur Robert Debré, Nîmes, 30029, France. sylvie.bouvier@chu-nimes.fr. Hauptthemen laut MEDLINE: Antibodies, Antiphospholipid, Immunoglobulin M, Antiphospholipid Syndrome, Extracellular Traps. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Antiphospholipid antibody syndrome (APS) is an acquired autoimmune disorder characterized by recurrent venous or arterial thrombosis and/or pregnancy complications. Recently, thrombotic APS was linked to increased neutrophil extracellular traps (NET) formation, suggesting an association between NETs and the severity of APS-related thrombosis. METHODS: We performed a retrospective study on patients tested for presence of antiphospholipid antibodies (990 negative and 374 positive) to evaluate the association between the neutrophil activation state, estimated by the neutrophil reactive index (NEU-RI), a parameter routinely available from some haematology analysers, and antiphospholipid antibodies. RESULTS: We do not observe a difference in NEU-RI values between positive and negative patients globally. However, interestingly, we highlight an association between high titers of IgM and low NEU-RI values indicating a lower neutrophil activation. CONCLUSION: Our data are in line with the recent questioning about the putative clinical consistency of positive solid-phase aPL IgM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Nîmes University Hospital, Place du Professeur Robert Debré, Nîmes, 30029, France. sylvie.bouvier@chu-nimes.fr.
- Desbrest Institute of Epidemiology and Public Health, Univ Montpellier, INSERM, University of Montpellier, Montpellier, France. sylvie.bouvier@chu-nimes.fr.
- Faculty of Pharmaceutical and Biological Sciences, University of Montpellier, Montpellier, France. sylvie.bouvier@chu-nimes.fr.
- Department of Hematology, Nîmes University Hospital, Place du Professeur Robert Debré, Nîmes, 30029, France.
- Desbrest Institute of Epidemiology and Public Health, Univ Montpellier, INSERM, University of Montpellier, Montpellier, France.
- Faculty of Pharmaceutical and Biological Sciences, University of Montpellier, Montpellier, France.
Zitieren
APA
Bouvier, S., Fortier, M., Nouvellon, E., Olivan, A., Chéa, M., & Gris, J. C. (2024). NEUT-RI, a surrogate marker of NETosis is lower in patients with strong IgM antiphospholipid antibodies. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-024-03001-1
Vancouver
Bouvier S, Fortier M, Nouvellon E, Olivan A, Chéa M, Gris JC. NEUT-RI, a surrogate marker of NETosis is lower in patients with strong IgM antiphospholipid antibodies. Journal of Thrombosis and Thrombolysis. 2024. doi:10.1007/s11239-024-03001-1
BibTeX
@article{Bouvier2024,
author = {Bouvier, Sylvie and Fortier, Mathieu and Nouvellon, Eva and Olivan, Ariane and Chéa, Mathias and Gris, Jean-Christophe},
title = {NEUT-RI, a surrogate marker of NETosis is lower in patients with strong IgM antiphospholipid antibodies},
journal = {Journal of Thrombosis and Thrombolysis},
year = {2024},
doi = {10.1007/s11239-024-03001-1}
}
EUVIMED